BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37897800)

  • 1. Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study.
    Krifors A; Blennow O; Påhlman LI; Gille-Johnson P; Janols H; Lipcsey M; Källman J; Tham J; Stjärne Aspelund A; Ljungquist O; Hammarskjöld F; Hällgren A; De Geer L; Lemberg M; Petersson J; Castegren M
    Infect Dis (Lond); 2024 Feb; 56(2):110-115. PubMed ID: 37897800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
    Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
    Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.
    Waldeck F; Boroli F; Zingg S; Walti LN; Wendel-Garcia PD; Conen A; Pagani JL; Boggian K; Schnorf M; Siegemund M; Abed-Maillard S; Michot M; Que YA; Bättig V; Suh N; Kleger GR; Albrich WC
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13059. PubMed ID: 36394086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
    Vanderbeke L; Janssen NAF; Bergmans DCJJ; Bourgeois M; Buil JB; Debaveye Y; Depuydt P; Feys S; Hermans G; Hoiting O; van der Hoven B; Jacobs C; Lagrou K; Lemiale V; Lormans P; Maertens J; Meersseman P; Mégarbane B; Nseir S; van Oers JAH; Reynders M; Rijnders BJA; Schouten JA; Spriet I; Thevissen K; Thille AW; Van Daele R; van de Veerdonk FL; Verweij PE; Wilmer A; Brüggemann RJM; Wauters J;
    Intensive Care Med; 2021 Jun; 47(6):674-686. PubMed ID: 34050768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis.
    Chong WH; Saha BK; Tan CK
    J Hosp Infect; 2022 Feb; 120():98-109. PubMed ID: 34843812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
    Schauwvlieghe AFAD; Rijnders BJA; Philips N; Verwijs R; Vanderbeke L; Van Tienen C; Lagrou K; Verweij PE; Van de Veerdonk FL; Gommers D; Spronk P; Bergmans DCJJ; Hoedemaekers A; Andrinopoulou ER; van den Berg CHSB; Juffermans NP; Hodiamont CJ; Vonk AG; Depuydt P; Boelens J; Wauters J;
    Lancet Respir Med; 2018 Oct; 6(10):782-792. PubMed ID: 30076119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
    Nyga R; Maizel J; Nseir S; Chouaki T; Milic I; Roger PA; Van Grunderbeeck N; Lemyze M; Totet A; Castelain S; Slama M; Dupont H; Sendid B; Zogheib E
    Am J Respir Crit Care Med; 2020 Sep; 202(5):708-716. PubMed ID: 32407157
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
    Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
    Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Lu LY; Lee HM; Burke A; Li Bassi G; Torres A; Fraser JF; Fanning JP
    Chest; 2024 Mar; 165(3):540-558. PubMed ID: 37742914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
    Reizine F; Pinceaux K; Lederlin M; Autier B; Guegan H; Gacouin A; Luque-Paz D; Boglione-Kerrien C; Bacle A; Le Daré B; Launey Y; Lesouhaitier M; Painvin B; Camus C; Mansour A; Robert-Gangneux F; Belaz S; Le Tulzo Y; Tadié JM; Maamar A; Gangneux JP
    J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34063556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive care management of influenza-associated pulmonary aspergillosis.
    Koehler P; Bassetti M; Kochanek M; Shimabukuro-Vornhagen A; Cornely OA
    Clin Microbiol Infect; 2019 Dec; 25(12):1501-1509. PubMed ID: 31102782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study.
    Waldeck F; Boroli F; Suh N; Wendel Garcia PD; Flury D; Notter J; Iten A; Kaiser L; Schrenzel J; Boggian K; Maggiorini M; Pugin J; Kleger GR; Albrich WC
    Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):1915-1923. PubMed ID: 32494955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
    Vanderbeke L; Jacobs C; Feys S; Reséndiz-Sharpe A; Debaveye Y; Hermans G; Humblet-Baron S; Lagrou K; Meersseman P; Peetermans M; Seldeslachts L; Vanstapel A; Vande Velde G; Van Wijngaerden E; Wilmer A; Verbeken E; De Hertogh G; Wauters J
    Am J Respir Crit Care Med; 2023 Aug; 208(3):301-311. PubMed ID: 37311243
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019.
    Wu CJ; Cia CT; Wang HC; Chen CW; Lin WC; Lee JC; Chen PS; Hsieh CC; Li WT; Su PL; Liao XM; Hsieh MI; Choi PC; Ko WC
    J Fungi (Basel); 2022 Jan; 8(1):. PubMed ID: 35049989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.